Welcome to our dedicated page for Huron Consul news (Ticker: HURN), a resource for investors and traders seeking the latest updates and insights on Huron Consul stock.
Huron Consulting Group Inc. reports developments tied to its work as a global professional services firm serving clients through Healthcare, Education and Commercial operating segments. Company news commonly covers financial results, revenue before reimbursable expenses, annual guidance, segment performance, and demand for services in strategy, operations, advisory, analytics and digital transformation.
Recurring updates also include completed acquisitions that expand Huron's healthcare and technology-enabled consulting capabilities, governance changes involving the board of directors, senior-level promotions, workplace recognition and earnings webcast schedules. Healthcare is a major reporting focus, including services for providers, payors and organizations modernizing operations and technology platforms.
Huron's Q4 2021 revenues surged by 25.2% to $248.3 million, up from $198.3 million in Q4 2020. The company reported a net income of $31.1 million, reversing a net loss of $6.1 million the previous year, aided by a $23.7 million gain from the sale of its Life Sciences business. Adjusted EBITDA grew 71.7% to $29.3 million, while diluted EPS improved to $1.45 from a loss of $0.28. For 2021, total revenues reached $905.6 million, up 7.3%, with guidance for 2022 set between $970 million to $1.03 billion.
Global professional services firm Huron (NASDAQ: HURN) will announce its financial results for the fourth quarter and full year ended Dec. 31, 2021, after market close on Thursday, Feb. 24, 2022. A conference call will follow at 5:00 p.m. Eastern Time featuring CEO James H. Roth and CFO John D. Kelly. Additionally, Huron is hosting a virtual Investor Day on Tuesday, Mar. 29, 2022, at 9:00 a.m. Eastern Time, to discuss company strategy with its leadership team. Details for both events will be available on Huron's website.
Huron (NASDAQ: HURN) announced the promotion of 26 managing directors and principals to enhance client support during transformation initiatives. CEO James H. Roth commended their dedication to delivering results and exemplifying the firm's values. The promotions reflect Huron's commitment to growth and operational excellence, particularly in healthcare and education sectors, as these leaders bring extensive experience in managing performance improvements, optimizing healthcare operations, and guiding strategic initiatives.
Huron (NASDAQ: HURN) has successfully acquired Perception Health Inc., enhancing its healthcare predictive analytics and data capabilities. This strategic acquisition aims to help clients leverage data for improved patient care and decision-making. Huron's CEO, James H. Roth, expressed enthusiasm about integrating Perception Health's expertise to better identify and manage patient risks. Post-acquisition, Perception Health will be included in Huron's Healthcare operating segment, reinforcing their commitment to data-driven healthcare solutions.
Huron (NASDAQ: HURN) announced its agreement to acquire Perception Health Inc., a predictive analytics firm focused on healthcare. This acquisition aims to enhance Huron's capabilities in delivering data insights for improved clinical and business decisions. With Perception Health's advanced analytics and data platform, Huron seeks to support healthcare providers in lowering costs and improving patient outcomes. The acquisition is expected to close in December, although specific terms were not disclosed.
Huron has acquired Whiteboard Higher Education, enhancing its capabilities in student enrollment and financial aid strategies. This acquisition strengthens Huron's position to support colleges and universities in recruiting diverse student populations. The merger combines Whiteboard’s analytics and outreach expertise with Huron’s strategic enrollment solutions, aimed at meeting annual enrollment targets effectively. The deal, which closed today, will integrate Whiteboard into Huron's Education segment, aligning both companies towards improved student success outcomes.
Summary not available.
Huron reported a 9.1% increase in revenues for Q3 2021, reaching $224.0 million compared to Q3 2020's $205.3 million. Net income rose 23.8% to $13.7 million, with diluted EPS from continuing operations up 28.0% to $0.64. Year-to-date revenues saw a 1.8% rise to $657.3 million. The company narrowed its 2021 revenue guidance to between $885.0 million and $905.0 million. Huron’s technology-related services contributed 40% to total revenue, indicating a strong focus on digital solutions.
Huron has finalized the divestiture of its life sciences commercial and R&D strategy business to Oliver Wyman, part of Marsh McLennan (NYSE: MMC). This strategic move allows Huron to focus more on enhancing its industry expertise in healthcare and education, alongside advancing its technology capabilities across all segments. The transaction is expected to streamline operations, directing resources towards core business areas, thereby aiming for improved client service and operational efficiency.
Huron (NASDAQ: HURN) is set to release its third-quarter financial results for the period ending September 30, 2021, after market hours on November 2, 2021. A conference call led by CEO James H. Roth and CFO John D. Kelly will occur the same day at 5:00 p.m. Eastern Time to discuss the results. The call will also be webcast on Huron's official website, with a replay available for 90 days post-event. Huron focuses on strategic growth and digital transformation for its clients.